Fact checked byJill Rollet

Read more

November 04, 2022
1 min read
Save

Top news from NAMS: Treatments for vaginal odor, vasomotor symptoms, sleep issues and more

Fact checked byJill Rollet
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The Healio editors have compiled the most read news from the NAMS annual meeting in October.

Readers were most interested in learning about a probiotic supplement for bothersome vaginal order, a non-hormonal medication for treating menopausal hot flashes and sleep disturbances, the effect of an endometriosis therapy on bone, the role of diet in menstrual pain and what hot flash severity may mean for later cognitive function. Links to the reports are below.

Healio highlights the top news from the NAMS annual meeting. Source: Adobe Stock
Healio highlights the top news from the NAMS annual meeting. Source: Adobe Stock

Probiotic supplement improves bothersome vaginal odor, symptoms at ‘warp speed’

Women who took a probiotic supplement for bothersome vaginal odor and symptoms such as irritation and painful urination reported substantial improvements within 2 weeks. Read more.

Fezolinetant improves vasomotor symptom severity, associated sleep disturbances

Women taking fezolinetant for moderate to severe vasomotor symptoms experienced a reduction in symptom severity and sleep disturbances. Read more.

Vasomotor symptoms linked to midlife brain health

Women who experienced vasomotor symptoms had elevated whole brain volume of white matter hyperintensities, which can affect brain health. Read more.

Diet plays role in menstrual pain intensity

Diets high in foods that cause inflammation, such as meat, sugar and coffee, increased the severity of menstrual pain for adolescents and young adults. Read more.

Relugolix efficacious, preserves bone for perimenopausal women with uterine fibroids

Potentially perimenopausal women who took relugolix combination therapy for uterine fibroids and heavy menstrual bleeding experienced significant reductions in menstrual bleeding and fibroid-related pain vs. those who took placebo. Read more.